Drug common name | Itacitinib |
INN | itacitinib |
Description | Itacitinib is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against tyrosine-protein kinase JAK1. In addition, it is known to target tyrosine-protein kinase JAK2. |
Classification | Small molecule |
Drug class | tyrosine kinase inhibitors: tyrosine kinase inhibitors; janus kinase inhibitors |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | N#CCC1(n2cc(-c3ncnc4[nH]ccc34)cn2)CN(C2CCN(C(=O)c3ccnc(C(F)(F)F)c3F)CC2)C1 |
PDB | — |
CAS-ID | 1334298-90-6 |
RxCUI | — |
ChEMBL ID | CHEMBL3622820 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 19J3781LPM (ChemIDplus, GSRS) |